Biogen | BIIB - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
AbbVie USD 14.39B 1.85B 2026-06
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
ALKERMES USD 375.31M 43.98M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Bayer EUR 6.33B 1.84B 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
Incyte USD 1.57B 400.89M 2026-06
Merck USD 12.09B 1.24B 2026-03
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.71B 602M 2026-06
Sanofi EUR 8.11B 343M 2026-03
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
United Therapeutics USD 683.8M 35.7M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06